Characteristics of 222 patients with NHL diagnosed during prospective follow-up according to the subtype diagnosed
| . | Burkitt (n = 20) . | Immunoblastic (n = 63) . | Other unknown/histology (n = 76) . | PBL (n = 63) . | P* . |
|---|---|---|---|---|---|
| Time of diagnosis, mo/y, median (IQR) | 12/96 | 09/96 | 07/97 | 10/95 | < .001 |
| (04/95-08/98) | (07/95-01/98) | (02/96-03/99) | (01/95-03/97) | ||
| Method of diagnosis, % definitive/presumptive/autopsy | 100.0/0.0/0.0 | 90.5/0.0/9.5 | 92.1/0.0/7.9 | 41.3/44.4/14.3 | < .001 |
| Sex, % female | 5.0 | 15.9 | 17.1 | 20.6 | .44 |
| HIV transmission group | .79 | ||||
| Homosexual, % | 45.0 | 52.4 | 54.0 | 49.2 | |
| Intravenous drug use, % | 25.0 | 23.8 | 13.2 | 25.4 | |
| Heterosexual, % | 25.0 | 17.5 | 23.7 | 22.2 | |
| Race, % Caucasian | 100.0 | 92.1 | 92.1 | 90.5 | .58 |
| AIDS diagnosis before NHL, % | 35.0 | 49.2 | 60.5 | 88.9 | < .001 |
| Age, y, median (IQR) | 42 (37-50) | 42 (34-49) | 41 (34-51) | 36 (32-44) | .02 |
| CD4 count, cells/mm3, median (IQR) | 168 (100-460) | 70 (26-201) | 81 (20-193) | 15 (3-40) | < .001 |
| Plasma viral load, log10 copies/mL, median (IQR) | 3.3 (2.7-4.7) | 4.4 (2.7-5.4) | 4.3 (3.0-5.1) | 4.6 (3.7-5.5) | .62 |
| . | Burkitt (n = 20) . | Immunoblastic (n = 63) . | Other unknown/histology (n = 76) . | PBL (n = 63) . | P* . |
|---|---|---|---|---|---|
| Time of diagnosis, mo/y, median (IQR) | 12/96 | 09/96 | 07/97 | 10/95 | < .001 |
| (04/95-08/98) | (07/95-01/98) | (02/96-03/99) | (01/95-03/97) | ||
| Method of diagnosis, % definitive/presumptive/autopsy | 100.0/0.0/0.0 | 90.5/0.0/9.5 | 92.1/0.0/7.9 | 41.3/44.4/14.3 | < .001 |
| Sex, % female | 5.0 | 15.9 | 17.1 | 20.6 | .44 |
| HIV transmission group | .79 | ||||
| Homosexual, % | 45.0 | 52.4 | 54.0 | 49.2 | |
| Intravenous drug use, % | 25.0 | 23.8 | 13.2 | 25.4 | |
| Heterosexual, % | 25.0 | 17.5 | 23.7 | 22.2 | |
| Race, % Caucasian | 100.0 | 92.1 | 92.1 | 90.5 | .58 |
| AIDS diagnosis before NHL, % | 35.0 | 49.2 | 60.5 | 88.9 | < .001 |
| Age, y, median (IQR) | 42 (37-50) | 42 (34-49) | 41 (34-51) | 36 (32-44) | .02 |
| CD4 count, cells/mm3, median (IQR) | 168 (100-460) | 70 (26-201) | 81 (20-193) | 15 (3-40) | < .001 |
| Plasma viral load, log10 copies/mL, median (IQR) | 3.3 (2.7-4.7) | 4.4 (2.7-5.4) | 4.3 (3.0-5.1) | 4.6 (3.7-5.5) | .62 |
P is derived from an overall comparison among all 4 subtypes.